![]() |
市場調査レポート
商品コード
1701725
感染管理市場の市場規模、シェア、成長分析、製品別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
感染管理市場の市場規模、シェア、成長分析、製品別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年04月05日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
|
感染管理市場規模は2023年に492億米ドルと評価され、2024年の525億9,000万米ドルから2032年には896億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.9%で成長する見通しです。
感染管理市場は、臨床転帰を成功させるために感染管理を重視する外科手術や治療手技の増加によって大きな成長を遂げています。COVID-19の大流行により、ヘルスケア施設、製薬会社、医療機器メーカー全体で滅菌・消毒の需要が高まっており、米国の除菌剤生産量は60%増加しています。滅菌方法の技術的進歩や滅菌サービスのアウトソーシング傾向の高まりがさらに市場拡大に寄与しています。さらに、感染予防対策の強化を推進することを目的とした政府の取り組みや、世界保健機関(WHO)のような組織による世界のガイドラインも、意識を高め予防行動を強化しています。こうした機運の高まりにより、感染管理市場は今後数年間で力強い成長を遂げるものと思われます。
Infection Control Market size was valued at USD 49.2 billion in 2023 and is poised to grow from USD 52.59 billion in 2024 to USD 89.69 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
The infection control market is experiencing significant growth driven by an increase in surgical and therapeutic procedures emphasizing infection management for successful clinical outcomes. The COVID-19 pandemic has heightened the demand for sterilization and disinfection across healthcare facilities, pharmaceutical companies, and medical device manufacturers, with sanitizer production in the U.S. rising by 60%. Technological advancements in sterilization methods and the growing trend of outsourcing sterilization services further contribute to market expansion. Additionally, government initiatives aimed at promoting heightened infection prevention measures and global guidelines from organizations like the World Health Organization are also fostering awareness and enhancing preventive actions. This collective momentum positions the infection control market for robust growth in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Infection Control Market Segments Analysis
Global Infection Control Market is segmented by Product, Application, Distribution Channel, End User and region. Based on Product, the market is segmented into Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces and Other Infection Control Products. Based on Application, the market is segmented into Surgical Instruments, Endoscopes, Ultrasound Probes and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Retail Sales and Third Party Distributors. Based on End User, the market is segmented into Hospitals, Clinics, Medical Device Companies,Pharmaceuticaland Biotechnology Companies, Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Infection Control Market
The Infection Control market is significantly driven by the escalating prevalence of healthcare-associated infections. This rise has heightened awareness among healthcare providers regarding the critical importance of effective infection prevention strategies, as these infections affect millions of patients annually. Consequently, there has been a surge in expenditure related to infection control practices and consumables, including personal protective equipment (PPE), disinfectants, and sterilization tools. Healthcare organizations are now adopting a comprehensive approach to infection control, prioritizing patient safety and the quality of care. As a result, there is an increasing demand for innovative solutions designed to minimize infection risks and enhance overall healthcare delivery.
Restraints in the Infection Control Market
One significant restraint in the infection control market is the high cost associated with advanced technologies. Implementing effective infection control strategies often necessitates substantial investments in sophisticated equipment, ongoing maintenance, and staff training. Smaller healthcare facilities may struggle to afford these essential solutions, which can hinder their ability to adhere to proper infection control protocols. Consequently, the financial burden posed by these expenditures can stifle market expansion and limit the adoption of innovative products and technologies. As many companies grapple with the challenge of delivering cost-effective infection control measures that meet stringent quality standards, this situation poses barriers to overall market growth.
Market Trends of the Infection Control Market
The Infection Control market is witnessing a significant trend towards high-tech advancements, driven by the increasing adoption of automation and digitalization in healthcare settings. Healthcare institutions are leveraging smart technologies, including automatic disinfection systems and real-time monitoring solutions, to enhance their infection prevention measures. These innovations streamline processes and provide crucial insights for compliance tracking and identifying improvement areas. As technology becomes embedded in infection control strategies, it is anticipated that patient safety and operational efficiency will experience a transformative boost, reshaping the landscape of infection management and positioning technology at the forefront of infection control initiatives.